A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial

A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial

Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting females more than males. Clinical symptoms, disease activity and comorbidities are more severe in females. Moreover, the choice of treatment for females is limited during childbearing age due to the side effects of cur...

Full description

Bibliographic Details
Main Authors:	Yingying Wan, Jiaxi Yang, Tianyue Ma, Wenqian Wang, Haonan Wang, Wenting Sun, Wanting Ye, Lin Yang, Qiuai Kou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Pharmacology
Subjects:	rheumatoid arthritis female randomized controlled trial double-blind placebo Chinese medicine
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.945565/full

Similar Items

Corrigendum: A Chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
by: Yingying Wan, et al.
Published: (2022-11-01)

The protective effect of traditional Chinese medicine Jinteng Qingbi granules on rats with rheumatoid arthritis
by: Yingying Wan, et al.
Published: (2024-03-01)

Should we reconsider the routine use of placebo controls in clinical research?
by: Avins Andrew L, et al.
Published: (2012-04-01)

How Placebo Needles Differ From Placebo Pills?
by: Younbyoung Chae, et al.
Published: (2018-06-01)

A virtual experimenter to increase standardization for the investigation of placebo effects
by: Bjoern Horing, et al.
Published: (2016-07-01)

EL PLACEBO: LUCES Y SOMBRAS Placebo: Lights and shadows
by: José Díaz Novás
Published: (2008-12-01)

A MULTICENTER, BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFET OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHRITIS. REPORT 2: THE ASSESSMENT OF THE STRUCTURE-MODIFYING EFFECT OF THE DRUG
by: L. I. Alekseeva, et al.
Published: (2014-06-01)

MULTICENTER DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFECT OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHROSIS. COMMUNICATION 1. EVALUATION OF THE SYMPTOM-MODIFYING EFFECT OF THE DRUG
by: Lyudmila Ivanovna Alekseeva, et al.
Published: (2013-12-01)

Acupuncture for Japanese Katakori (Chronic Neck Pain): A Randomized Placebo-Controlled Double-Blind Study
by: Nobuari Takakura, et al.
Published: (2023-12-01)

Hormone Replacement Therapy and Menopause: A Review of Randomized, Double-Blind, Placebo-Controlled Trials
by: Chueh Chang
Published: (2003-06-01)

A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis
by: Uchio Y, et al.
Published: (2018-04-01)

Comprehensive analysis of treatment response phenotypes in rheumatoid arthritis for pharmacogenetic studies
by: Kristopher A. Standish, et al.
Published: (2017-05-01)

Validación de un nuevo método de acupuntura placebo con potencial doble ciego. Fase II: cegamiento del operador
by: Alejandro Francia, et al.

Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
by: Mamta K. Jain, et al.
Published: (2022-09-01)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Loki zupa in Patients With Chronic Asthma
by: Yubao Lv, et al.
Published: (2018-04-01)

Safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of WBP216, a novel IL-6 monoclonal antibody, in patients with rheumatoid arthritis: A phase Ia randomized placebo-controlled study
by: Xiaomei Leng, et al.
Published: (2023-02-01)

Placebo Studies in Developing Countries
by: Scott Korotkin
Published: (2014-09-01)

A randomized, double-blind, placebo-controlled trial of the effect of monthly vitamin D supplementation in mild psoriasis
by: Paul Jarrett, et al.
Published: (2018-05-01)

Evaluation of the safety and efficacy of a Fuling-Zexie decoction for people with asymptomatic hyperuricemia: protocol for a prospective, double-blinded, randomized, placebo-controlled clinical trial
by: Jingyao Yan, et al.
Published: (2022-06-01)

El placebo y el efecto placebo
by: Rosa María Lam Díaz, et al.

Placebos and Medical Education
by: Amir Raz, et al.
Published: (2020-12-01)

Can the Open Label Placebo Rationale Be Optimized?
by: Uwe Heiss, et al.
Published: (2021-09-01)

LISTENING TO THE PLACEBO, OR HOW TO FIND OUT WHY TREATMENTS WORK
by: Miguel A. Vallejo Pareja, et al.
Published: (2020-09-01)

Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI study
by: Hauke Basedau, et al.
Published: (2024-01-01)

European Headache Federation recommendations for placebo and nocebo terminology
by: Dimos D. Mitsikostas, et al.
Published: (2020-09-01)

Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers
by: Silverstone Peter H, et al.
Published: (2012-03-01)

Herbal Medicine Formulas for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Clinical Trials
by: Chun-Shuo Shan, et al.
Published: (2018-11-01)

Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups? A protocol for a meta-epidemiological study of PDE-5 inhibitors
by: Feys Frederik, et al.
Published: (2012-11-01)

Placebo and nocebo
by: Luana Colloca
Published: (2009-06-01)

Glycemic Variability in Patients with Type 2 Diabetes Mellitus (T2DM): The Role of Melatonin in a Crossover, Double-Blind, Placebo-Controlled, Randomized Study
by: Wagner Martorina, et al.
Published: (2023-08-01)

Efficacy and Safety of Fluticasone Furoate Nasal Spray in Japanese Children with Perennial Allergic Rhinitis: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
by: Kimihiro Okubo, et al.
Published: (2014-01-01)

Challenging Received Wisdom: Antidepressants and the Placebo Effect
by: Irving Kirsch
Published: (2020-12-01)

Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture
by: Soyeon Cheon, et al.
Published: (2018-01-01)

Analgesic efficacy of diazepam and placebo in patients with temporomandibular disorders: A double blind randomized clinical trial
by: G V Pramod, et al.
Published: (2011-01-01)

Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial
by: Nils Venhoff, et al.
Published: (2021-08-01)

An oral French maritime pine bark extract improves hair density in menopausal women: A randomized, placebo‐controlled, double blind intervention study
by: Carr Cai, et al.
Published: (2023-01-01)

Expectations: How and when do they contribute to placebo analgesia?
by: Sophie Rosenkjær, et al.
Published: (2022-09-01)

a placebo control study of the effect of nigella sativa fixed oil on the healing rate of recurrent aphthous ulceration
by: samara M. abdalli, et al.
Published: (2006-07-01)

Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression
by: Johannes A. C. Laferton, et al.
Published: (2018-09-01)

Super Placebos: A Feasibility Study Combining Contextual Factors to Promote Placebo Effects
by: Jay A. Olson, et al.
Published: (2021-03-01)